Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Takuya Ando is active.

Publication


Featured researches published by Takuya Ando.


Clinical Cancer Research | 2006

RNASEN Regulates Cell Proliferation and Affects Survival in Esophageal Cancer Patients

Nobuyoshi Sugito; Hideyuki Ishiguro; Yoshiyuki Kuwabara; Masahiro Kimura; Akira Mitsui; Hiroki Kurehara; Takuya Ando; Ryota Mori; Nobuhiro Takashima; Ryo Ogawa; Yoshitaka Fujii

Purpose: MicroRNAs (miRNA) are small noncoding RNAs thought to be involved in physiologic and developmental processes by negatively regulating the expression of target genes. Little is known about the role of miRNAs in normal and cancer cells. It is possible that deregulation of miRNA may contribute to the oncogenesis of some cancers. We studied the expression level of the miRNA processing enzyme (DICER1, DGCR8, and RNASEN) in esophageal squamous cell carcinoma (ESCC). Experimental Design: The expression levels of DICER1, DGCR8, and RNASEN mRNA in 73 ESCC tissues were compared with that in corresponding normal esophageal epithelium by Taqman real-time reverse-transcription PCR. We also examined RNASEN protein expression in 27 cell lines. The role of RNASEN in cell proliferation in ESCC cells was assessed by small interfering RNA. Paraffin sections of ESCC patients were immunohistochemically investigated. Results: We found that RNASEN expression levels were enhanced in a fraction of esophageal cancers. Multivariate Cox regression analysis showed that the prognostic effect of RNASEN (P = 0.0036) seems to be independent of disease stage (P = 0.0060). Knockdown of RNASEN in esophageal cancer cell lines resulted in a 46% to 85% reduction in cell number. In an immunohistochemical study, the intensity of RNASEN expression was often increased in the tumor compared with that in normal epithelium. Conclusions: The relationship between the RNASEN expression and the prognosis of the ESCC patients warrants a further study on the role of miRNA and tumor progression.


Diseases of The Esophagus | 2008

Relationship between expression of 5-fluorouracil metabolic enzymes and 5-fluorouracil sensitivity in esophageal carcinoma cell lines

Takuya Ando; Hideyuki Ishiguro; Yoshiyuki Kuwabara; Masahiro Kimura; Akira Mitsui; Nobuyoshi Sugito; Ryota Mori; Ryo Ogawa; Takeyasu Katada; Yoshitaka Fujii

5-Fluorouracil (5-FU) is a key drug in the treatment of esophageal squamous cell carcinoma (ESCC). Gene expression of 5-FU metabolic enzymes such as thymidylate synthase (TS), thymidine phosphorylase (TP), dihydropyrimidine dehydrogenase (DPD) and orotate phosphoribosyl transferase (OPRT), has recently been investigated in order to predict the 5-FU sensitivity of several cancers. We examined the relationship between such gene expression and 5-FU sensitivity in 25 ESCC cell lines. TS, DPD, TP and OPRT mRNA levels were assessed by real-time polymerase chain reaction. The 50% inhibitory concentrations (IC50) of 5-FU in 25 ESCC cell lines were determined by cell proliferation assay. IC50 values for 5-FU ranged from 1.00 to 39.81 micromol/L. There were significant positive correlations between IC50 and TS mRNA expression (R(2) = 0.5781, P < 0.0001) and DPD mRNA expression (R(2) = 0.3573, P = 0.0016). There were no correlations between IC50 and TP or OPRT mRNA expression. TS and DPD mRNA expression levels may be useful indicators in predicting the anti-tumor activity of 5-FU in ESCC.


Journal of The American College of Surgeons | 2014

A New Technique for Shaping the Gastric Tube, Using Both Radial and Linear Staplers

Masahiro Kimura; Yoshiyuki Kuwabara; Hideyuki Ishiguro; Takuya Ando; Ryo Ogawa; Midori Shiozaki; Tatsuya Tanaka; Hiromitsu Takeyama

One factor influencing surgery for esophageal cancer is the reconstruction technique, which may involve constructing a tube from the stomach or the intestines. Good blood flow and adequate length are necessary. Gastric tube formation became easier with the availability of improved surgical staplers, but gastric tube necrosis and leakage may still occur. Therefore, a simple technique providing good blood flow to the end of the gastric tube is needed. One method is called the whole stomach technique: the surgeon excises the small part of the gastric wall supplied by the left gastric artery. Another is called the gastric tube technique: the surgeon divides the stomach from the lesser curvature along the axis of the greater curvature. But the gastric tube method is so difficult that different devices are used in each institution. We use the gastric tube method, except in patients with gastric cancer or patients with a history of gastrectomy. One reason for choosing this method is that it provides sufficient length. Length is never a problem, even in the case of laryngo-esophagotomy. With a linear cutting stapler, shaping the gastric tube is comparatively easy and time-saving. Since 2012, we have used the EndoGIA60 with Tri-Staple (Covidien Japan). To shape a long, slender tube, we usually use 6 or 7 linear staplers. The first problem is an irregular section of a knot, which causes no trouble if the serial stapling is in the same direction (Fig. 1). But once the direction shifts, inserting a linear stapler becomes difficult, and the knot becomes more notched. To shape a long tube, the first 2 staplers must be at a nearly right angle. If the area below is the remaining side, the section is more notched. These sides are vulnerable, with limited blood flow. Therefore, we developed a new technique using 2 types of staplers.


Oncology Reports | 2007

The overexpression of caveolin-1 and caveolin-2 correlates with a poor prognosis and tumor progression in esophageal squamous cell carcinoma.

Takuya Ando; Hideyuki Ishiguro; Masahiro Kimura; Akira Mitsui; Yoichiro Mori; Nobuyoshi Sugito; Keisuke Tomoda; Ryota Mori; Koshiro Harada; Takeyasu Katada; Ryo Ogawa; Yoshitaka Fujii; Yoshiyuki Kuwabara


Diseases of The Esophagus | 2006

Decreased expression of Ndrg1 is correlated with tumor progression and poor prognosis in patients with esophageal squamous cell carcinoma

Takuya Ando; H. Ishiguro; Masahiro Kimura; Akira Mitsui; Hiroki Kurehara; Nobuyoshi Sugito; Keisuke Tomoda; Ryota Mori; Nobuhiro Takashima; Ryo Ogawa; Y. Fujii; Yoshiyuki Kuwabara


Oncology Reports | 2006

Expression and prognostic roles of PABPC1 in esophageal cancer : Correlation with tumor progression and postoperative survival

Nobuhiro Takashima; Hideyuki Ishiguro; Yoshiyuki Kuwabara; Masahiro Kimura; Nobuhiro Haruki; Takuya Ando; Hiroki Kurehara; Nobuyoshi Sugito; Ryota Mori; Yoshitaka Fujii


International Journal of Oncology | 2007

A novel gene, RSRC2, inhibits cell proliferation and affects survival in esophageal cancer patients.

Hiroki Kurehara; Hideyuki Ishiguro; Masahiro Kimura; Akira Mitsui; Takuya Ando; Nobuyoshi Sugito; Ryota Mori; Nobuhiro Takashima; Ryo Ogawa; Yoshitaka Fujii; Yoshiyuki Kuwabara


Oncology Reports | 2006

Expression of ACP6 is an independent prognostic factor for poor survival in patients with esophageal squamous cell carcinoma.

Takuya Ando; Hideyuki Ishiguro; Yoshiyuki Kuwabara; Masahiro Kimura; Akira Mitsui; Hiroki Kurehara; Nobuyoshi Sugito; Keisuke Tomoda; Ryota Mori; Nobuhiro Takashima; Ryo Ogawa; Yoshitaka Fujii


Journal of The American College of Surgeons | 2004

Billroth I gastroduodenostomy using a hemi-double stapling technique 1

Yoshiyuki Kuwabara; Noriyuki Shinoda; Atsushi Sato; Masahiro Kimura; Hideyuki Ishiguro; Hironori Sugiura; Tadashi Tanaka; Takuya Ando; Y. Fujii; Yoshitaka Fujii


Jpn J Gastroenterol Surg, Nihon Shokaki Geka Gakkai zasshi | 2001

A Case of Splenic Hamartoma.

Takuya Ando; Kenichi Sakakibara; Hideki Tsuzi; Naoki Nishiwaki; Kotaro Mizuno; Shigemitsu Ando; Nobuyuki Miyake; Kazuhiro Tashiro

Collaboration


Dive into the Takuya Ando's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ryo Ogawa

Nagoya City University

View shared research outputs
Top Co-Authors

Avatar

Ryota Mori

Nagoya City University

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge